Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care

Status: Terminated

Location: See location...

Intervention Type: Behavioral

Study Type: Interventional

Study Phase: Not Applicable

SUMMARY

The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.

Eligibility

Participation Requirements

Sex: All

Minimum Age: 8

Maximum Age: 12

Healthy Volunteers: f

View:

⁃ For parent/guardian participants:

• Speaks English fluently

• Able to independently consent

• Has adequate corrected vision to use the ECA-HPV system (based on their ability to go through the consent form)

• Has adequate hearing to use the ECA-HPV system (based on their ability to hear the research staff member conducting the consent process)

• Has a smartphone that is able to support the ECA-HPV app

⁃ For adolescent participants:

• Is between the ages of 9-12 at the time of the index (first) well child visit

• Has received either 1 or none of the HPV vaccine series

• Speaks English fluently

• Able to independently assent

• Has adequate corrected vision to use the ECA-HPV system

• Has adequate hearing to use the ECA-HPV system

• Has a smartphone or has access to parent/guardian's smartphone (that is able to support the ECA-HPV app)

• Has an upcoming well child visit at Boston Medical Center

Locations

United States

Massachusetts

Boston Medical Center

Boston

Time Frame

Start Date: 2024-11-13

Completion Date: 2025-04-01

Participants

Target number of participants: 29

Treatments

Active_comparator: Usual Care

An internet-based measure, REDCap, will be used for parent/guardian and adolescent participants to complete surveys at baseline, after the index well child visit, and after the second well child visit. Both parent/guardian and adolescent participants do not have access to the ECA-HPV app. Adolescent participants will receive usual standard of care.

Experimental: ECA-HPV App with Clinic Notification and Adolescent Functions Disabled

The ECA-HPV (Embodied Conversational Agent adapted for this project) system comprises of a smartphone-based ECA parent/guardian interface, where the parent/guardian participants can receive HPV vaccine promotion and counseling from an interactive agent. The clinic notification feature is disabled on the app. Adolescent participants do not receive the adolescent version of the ECA-HPV app. An internet-based measure, REDCap, will be used for parent/guardian and adolescent participants to complete surveys at baseline, after the index well child visit, and after the second well child visit.

Experimental: ECA-HPV App with Clinic Notification Function Enabled

The ECA-HPV (Embodied Conversational Agent adapted for this project) system comprises of a smartphone-based ECA parent/guardian interface, where the parent/guardian participants can receive HPV vaccine promotion and counseling from an interactive agent. With the clinic notification function enabled, parent/guardian participants can communicate their concerns, questions, and logistical barriers to the clinic staff. Adolescent participants do not receive the adolescent version of the ECA-HPV app. An internet-based measure, REDCap, will be used for parent/guardian and adolescent participants to complete surveys at baseline, after the index well child visit, and after the second well child visit.

Experimental: ECA-HPV App with Adolescent Function Enabled

The ECA-HPV (Embodied Conversational Agent adapted for this project) system comprises of a smartphone-based ECA parent/guardian interface, where the parent/guardian participants can receive HPV vaccine promotion and counseling from an interactive agent. Adolescent participants receive the adolescent version of the ECA-HPV app, which includes age-appropriate education and adolescent-focused engagement features, like games. The clinic notification feature is disabled on both the parent/guardian and adolescent apps. An internet-based measure, REDCap, will be used for parent/guardian and adolescent participants to complete surveys at baseline, after the index well child visit, and after the second well child visit.

Experimental: ECA-HPV App with Clinic Notification and Adolescent Functions Enabled

Participants will receive the full ECA-HPV (Embodied Conversational Agent adapted for this project) system on their smartphone app, which includes both the clinic notification and adolescent functions enabled. With the clinic notification function enabled, parent/guardian participants can communicate their concerns, questions, and logistical barriers to the clinic staff. Adolescent participants receive the adolescent version of the ECA-HPV app, which includes age-appropriate education and adolescent-focused engagement features, like games. An internet-based measure, REDCap, will be used for parent/guardian and adolescent participants to complete surveys at baseline, after the index well child visit, and after the second well child visit.

Related Therapeutic Areas

Human Papillomavirus Infection

Similar Clinical Trials

View All

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care

Similar Clinical Trials

Effects of Estrogen-like Chinese Medicine and Vaginal Lactobacillus on HPV Clearance and Vaginal Microbiota Change in Women With Persistent HPV Infection

Effects of Estrogen-like Chinese Medicine and Vaginal Lactobacillus on HPV Clearance and Vaginal Microbiota Change in Women With Persistent HPV Infection

Integrated Service Delivery to Improve Adolescent Health and HPV Vaccination in Lao PDR: a Quasi-Experimental Mixed-Methods Study

Integrated Service Delivery to Improve Adolescent Health and HPV Vaccination in Lao PDR: a Quasi-Experimental Mixed-Methods Study

Clinical Evaluation of Self-collected Urine Samples for the Detection of Human Papillomavirus in Males

Clinical Evaluation of Self-collected Urine Samples for the Detection of Human Papillomavirus in Males